| Medtronic Strikes Deal With Nile - Zacks.com |
|
|
Zacks.com Medtronic (MDT - Analyst Report) recently entered into an agreement with Nile Therapeutics for the latter's proprietary peptide 'cenderitide', which is meant to treat heart failure and renal disease. Medtronic will provide adequate funding and offer |